IDEX (IEX)
(Delayed Data from NYSE)
$208.73 USD
-1.77 (-0.84%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $208.77 +0.04 (0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$208.73 USD
-1.77 (-0.84%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $208.77 +0.04 (0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Zacks News
IDEX Boosts Product Portfolio With the Acquisition of Mott
by Zacks Equity Research
IEX is set to penetrate and diversify its offerings in key markets, such as semiconductor fabrication, medical technologies and water purification, with the acquisition of Mott.
Idex (IEX) Up 4.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Avoid Investing in IDEX (IEX) for Now
by Zacks Equity Research
Softness in the analytical instrumentation, life sciences and semiconductor markets and increasing operating expenses weigh on IDEX (IEX). Unfavorable foreign currency movement is an added concern.
Idex (IEX) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Idex (IEX) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
IDEX (IEX) Q2 Earnings Top Estimates, Sales Miss, '24 View Down
by Zacks Equity Research
IDEX's (IEX) second-quarter 2024 net sales decrease 5% due to lower sales in the Fluid & Metering Technologies and Health & Science Technologies segments.
Idex (IEX) Beats Q2 Earnings Estimates
by Zacks Equity Research
Idex (IEX) delivered earnings and revenue surprises of 0.98% and 2.84%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
IDEX (IEX) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Weakness in the HST and FMT segments and escalating operating expenses are likely to hurt IDEX's (IEX) second-quarter results.
Analysts Estimate Helios Technologies (HLIO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Helios Technologies (HLIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zebra Technologies (ZBRA) to Post Q2 Earnings: What to Expect
by Zacks Equity Research
Zebra Technologies' (ZBRA) Q2 results are likely to benefit from the solid demand for services, software and RFID products. Weakness in the printing end market is likely to hurt its results.
Will Idex (IEX) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Idex (IEX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Stanley Black (SWK) to Report Q2 Earnings: Is a Beat in Store?
by Zacks Equity Research
Stanley Black's (SWK) Q2 2024 results are likely to gain from strength in the Engineered Fastening unit. However, the weakness in the Industrial and Tools & Outdoor segments is likely to have adversely impacted its performance.
Earnings Preview: Idex (IEX) Q2 Earnings Expected to Decline
by Zacks Equity Research
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain IDEX (IEX) in Your Portfolio
by Zacks Equity Research
Strength in the FSDP segment poises IDEX (IEX) well for growth. The company's measures to reward its shareholders are promising.
IDEX (IEX) to Benefit From Business Strength Amid Headwinds
by Zacks Equity Research
IDEX (IEX) is poised to benefit from strength across its FSDP segment, acquired businesses and shareholder-friendly policies. However, softness in its HST unit is concerning.
What's in the Offing for Donaldson (DCI) This Earnings Season?
by Zacks Equity Research
Donaldson's (DCI) third-quarter fiscal 2024 results are likely to benefit from solid momentum in the Industrial Solutions segment, partly offset by cost inflation.
Idex (IEX) Down 3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Enersys (ENS) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Enersys' (ENS) fiscal Q4 results benefit from the solid performance of the Motive Power segment and the lower cost of sales.
Nordson's (NDSN) Q2 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Nordson's (NDSN) second-quarter fiscal 2024 revenues increase 0.1% due to strong momentum in the Industrial Precision Solutions and Medical and Fluid Solutions segments.
What's in the Offing for Nordson (NDSN) This Earnings Season?
by Zacks Equity Research
Nordson's (NDSN) second-quarter fiscal 2024 results are likely to benefit from solid momentum in the Industrial Precision Solutions segment, partly offset by cost inflation.
Energous (WATT) Q1 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Energous' (WATT) first-quarter 2024 revenues decline 34% year over year due to a decrease in transmitter sales volume.
Here's Why Hold Strategy is Apt for IDEX (IEX) Stock Now
by Zacks Equity Research
Strength in the fire and safety businesses within the FSDP segment and accretive acquisitions augur well for IDEX (IEX). The company's measures to reward its shareholders are encouraging.
Berry Global (BERY) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Berry Global's (BERY) second-quarter fiscal 2024 revenues decline 6.4% year over year due to a 5% negative impact from lower resin costs.
Kennametal (KMT) Q3 Earnings Miss Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Kennametal's (KMT) fiscal third-quarter 2024 revenues decrease 3.8% due to the lackluster performance of the Metal Cutting segment.
DNOW Gears Up to Report Q1 Earnings: What Should You Expect?
by Zacks Equity Research
DNOW's Q1 results are likely to gain from stronger project activity and an increase in international rig count. However, the higher cost of products is likely to have ailed its performance.
Axon Enterprise (AXON) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Axon Enterprise's (AXON) Q1 revenues increase 34.3% year over year, driven by the impressive performance of its Software & Sensors and TASER segments.